A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Clinical trial NCT04846998 · COMPLETED

Trial details

NCT number: NCT04846998
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2021-03-25
Primary completion: 2021-05-04
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.